Registry of Lobbyists
| Organization: | Innovative Medicines Canada/Médicaments novateurs Canada |
| Associated registration: | 957857-371-129 |
| Communication date: | 2025-12-01 |
| Posted date: | 2026-01-12 |
| Designated Public Office Holders who participated in the communication: |
Nasser Haidar,
Senior Policy Advisor
Office of the Min. responsible for Canada-U.S. Trade, Intergovernmental Affairs and One Canadian Economy, Intergovernmental Affairs Secretariat (IGA) Footnote1 Miro Froehlich, Director of Policy Office of the President of the King's Privy Council for Canada, Minister responsible for Canada-U.S. Trade, Intergovernmental Affairs, Internal Trade, Privy Council Office (PCO) Galen Richardson, Director of Stakeholder Relations, Office of President of the King’s Privy Council for Canada and Minister Responsible for Canada- U.S. Trade, Intergo Privy Council Office (PCO) |
||||||
|
|||||||
| Responsible Officer who filed this communication report: | Bettina Hamelin | ||||||
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |||||||
|
|||||||